The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
By 2030, What Market Size Is The Gastrointestinal Bleeding Treatment Devices Market Expected To Reach Based On Its 2026 Value?
The gastrointestinal bleeding treatment devices market has seen significant expansion in recent years. It is anticipated to increase from $0.92 billion in 2025 to $1 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.7%. The expansion observed in prior periods can be attributed to a rising occurrence of gastrointestinal disorders, an increasing prevalence of peptic ulcer disease, the growth of endoscopic diagnostic procedures, an uptick in hospital-based GI interventions, and the availability of sophisticated endoscopy equipment.
The gastrointestinal bleeding treatment devices market is anticipated to experience substantial growth in the upcoming years, with its valuation expected to reach $1.39 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 8.6%. This expansion during the forecast period is driven by factors such as the increasing adoption of next-generation endoscopic devices, a rising demand for outpatient GI procedures, a growing focus on early bleeding detection, the continued expansion of ambulatory surgical centers, and increased investments in advanced GI care technologies. Key trends influencing this period include the increasing adoption of advanced endoscopic hemostasis devices, a rising use of minimally invasive GI bleeding treatments, a growing demand for precision thermal ablation tools, the expansion of mechanical hemostatic solutions, and an enhanced focus on rapid bleeding control technologies.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5307&type=smp
Which Major Drivers Are Influencing The Expansion Of The Gastrointestinal Bleeding Treatment Devices Market?
The growing prevalence of gastrointestinal disorders is anticipated to significantly boost market profitability. These conditions often stem from various factors, including an insufficient fiber diet, stress, inadequate hydration, high dairy consumption, a sedentary lifestyle, advancing age, and genetic predispositions. A notable example comes from a 2023 report by the National Library of Medicine, a US-based national library (as cited in October 2024), which stated that 825 per 100,000 Canadians are affected by inflammatory bowel disease (IBD), totaling over 320,000 individuals. Furthermore, projections suggest this figure could escalate to 1.1% of the population, equating to around 470,000 Canadians, by 2035. Consequently, the rising occurrence of conditions impacting the GI tract is a significant market driver.
How Are Different Segments Classified In The Gastrointestinal Bleeding Treatment Devices Market Segment Analysis?
The gastrointestinal bleeding treatment devices market covered in this report is segmented –
1) By Product: Endoscopic Thermal Hemostasis Devices, Mechanical Hemostasis Devices, Injection-Based Hemostasis Devices, Topical Hemostatic Agents & Powders, Combination Or Multimodal Hemostasis Devices
2) By GI Tract Division: Upper GI Tract, Lower GI Tract
3) By End User: Hospitals Or Clinics, Ambulatory Surgical Centers, Other End-users
Subsegments:
1) By Endoscopic Thermal Hemostasis Devices: Electrocautery And Electrosurgical Coagulation Devices, Argon Plasma Coagulation (APC) Devices, Radiofrequency Ablation (RFA) Devices, Laser Coagulation Devices, Heater Probe Devices
2) By Mechanical Hemostasis Devices: Hemostatic Clips (Through-the-Scope And Over-the-Scope Clips), Endoscopic Band Ligation Devices, Endoscopic Suturing Devices, Compression And Tamponade Devices
3) By Injection-Based Hemostasis Devices: Epinephrine Injection Systems, Sclerosant Injection Devices, Cyanoacrylate Glue Injection Devices, Saline And Combination Injection Systems
4) By Topical Hemostatic Agents And Powders: Hemostatic Powder Sprays, Absorbable Hemostatic Agents, Fibrin-Based Sealants, Collagen-Based Hemostatic Agents
5) By Combination And Multimodal Hemostasis Devices: Thermal And Mechanical Combination Systems, Injection And Mechanical Combination Systems, Integrated Multimodal Endoscopic Hemostasis Platforms
Which Trends Are Shaping The Gastrointestinal Bleeding Treatment Devices Market?
Major companies operating in the gastrointestinal bleeding treatment devices market are focusing on the development of advanced solutions, such as Hemospray, to improve the effectiveness of treating acute bleeding in the GI tract. Hemospray is a hemostatic powder designed to manage and control active bleeding within the gastrointestinal tract. For instance, in January 2024, AIG Hospitals, an India-based hospital, introduced Hemospray, representing a significant breakthrough in controlling GI bleeding. This hemostatic agent is specifically engineered for use in endoscopic procedures to manage acute gastrointestinal bleeding. Hemospray is notable for its ease of use, strong safety profile, and its capability to control a wide range of GI bleeds, from peptic ulcers to variceal hemorrhages.
Who Are The Companies Driving Activity In The Gastrointestinal Bleeding Treatment Devices Market?
Major companies operating in the gastrointestinal bleeding treatment devices market are CONMED Corporation, Boston Scientific Corporation, Ovesco Endoscopy AG, Olympus Corporation, Cook Medical, Erbe Elektromedizin GmbH, Steris plc, Medtronic plc, Johnson & Johnson, Abbott Laboratories, Fujifilm Holdings Corporation, Pentax Medical, Merit Medical Systems, Teleflex Incorporated, AngioDynamics, BTG International Ltd., Smiths Medical, Terumo Corporation, Nipro Corporation, C. R. Bard Inc., EndoChoice Holdings Inc., GI Supply Inc., Hemostasis LLC
Get The Full Gastrointestinal Bleeding Treatment Devices Market Report:
Which Region Holds The Highest Market Share In The Gastrointestinal Bleeding Treatment Devices Market?
North America was the largest region in the gastrointestinal bleeding treatment devices market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the gastrointestinal bleeding treatment devices market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Gastrointestinal Bleeding Treatment Devices Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=5307&type=smp
Browse Through More Reports Similar to the Global Gastrointestinal Bleeding Treatment Devices Market 2026, By The Business Research Company
Bleeding Disorders Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report
Gastrointestinal Devices Market Report 2026
https://www.thebusinessresearchcompany.com/report/gastrointestinal-devices-global-market-report
Bleeding Disorder Testing Market Report 2026
https://www.thebusinessresearchcompany.com/report/bleeding-disorder-testing-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model